BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12048351)

  • 1. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice.
    Iwasaki T; Yamashita K; Tsujimura T; Kashiwamura S; Tsutsui H; Kaisho T; Sugihara A; Yamada N; Mukai M; Yoneda T; Okamura H; Akedo H; Terada N
    J Immunother; 2002; 25 Suppl 1():S52-60. PubMed ID: 12048351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice.
    Zhang H; Yano S; Miki T; Goto H; Kanematsu T; Muguruma H; Uehara H; Sone S
    Clin Exp Metastasis; 2003; 20(2):153-9. PubMed ID: 12705636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
    Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H
    Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone resorption activity of osteolytic metastatic lung and breast cancers.
    Shih LY; Shih HN; Chen TH
    J Orthop Res; 2004 Nov; 22(6):1161-7. PubMed ID: 15475192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
    Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
    Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.
    Nishio S; Yamada N; Ohyama H; Yamanegi K; Nakasho K; Hata M; Nakamura Y; Fukunaga S; Futani H; Yoshiya S; Ueda H; Taniguchi M; Okamura H; Terada N
    Cancer Sci; 2008 Jan; 99(1):113-20. PubMed ID: 17949451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice.
    Sasaki A; Kitamura K; Alcalde RE; Tanaka T; Suzuki A; Etoh Y; Matsumura T
    Int J Cancer; 1998 Jul; 77(2):279-85. PubMed ID: 9650565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
    Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
    Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
    Tester AM; Sharp JA; Dhanesuan N; Waltham M; Thompson EW
    Clin Exp Metastasis; 2002; 19(5):377-83. PubMed ID: 12198765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose recombinant interleukin-18 induces an effective Th1 immune response to murine MOPC-315 plasmacytoma.
    Jonak ZL; Trulli S; Maier C; McCabe FL; Kirkpatrick R; Johanson K; Ho YS; Elefante L; Chen YJ; Herzyk D; Lotze MT; Johnson RK
    J Immunother; 2002; 25 Suppl 1():S20-7. PubMed ID: 12048347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
    Otsuka S; Hanibuchi M; Ikuta K; Yano S; Goto H; Ogino H; Yamada T; Kakiuchi S; Nishioka Y; Takahashi T; Sone S
    Oncol Res; 2009; 17(11-12):581-91. PubMed ID: 19806789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of IL-8 results in suppression of bone metastasis by lung cancer cells in vivo.
    Iguchi H; Ono M; Matsushima K; Kuwano M
    Int J Oncol; 2000 Aug; 17(2):329-33. PubMed ID: 10891543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
    Muguruma H; Yano S; Kakiuchi S; Uehara H; Kawatani M; Osada H; Sone S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8822-8. PubMed ID: 16361571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
    Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
    Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.